S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals! (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Bill Gates is raving about WHAT?! (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Recession risks are fading, business economists say, but political tensions pose threat to economy
Bill Gates is raving about WHAT?! (Ad)
Stock market today: World shares mostly higher after S&P 500 tops 5,000
Biden's campaign joins TikTok, even as administration warns of national security concerns with app

SVB Securities Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at SVB Securities. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by SVB Securities.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Galecto, Inc. stock logo
GLTO
Galecto
$0.62
+1.5%
8/15/2023Downgraded bySVB Securities-Outperform -> Market PerformLowView details for SVB Securities rating of Galecto (NASDAQ:GLTO) on 8/15/2023
Viracta Therapeutics, Inc. stock logo
VIRX
Viracta Therapeutics
$0.62
+10.7%
8/15/2023Target Lowered bySVB Securities-Outperform -> Outperform$10.00 -> $5.00LowView details for SVB Securities rating of Viracta Therapeutics (NASDAQ:VIRX) on 8/15/2023
Centessa Pharmaceuticals plc stock logo
CNTA
Centessa Pharmaceuticals
$9.26
+24.1%
8/15/2023Target Raised bySVB Securities-Outperform -> Outperform$6.00 -> $11.00LowView details for SVB Securities rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 8/15/2023
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
$2.16
-2.3%
8/15/2023Initiated bySVB Securities-Market PerformLowView details for SVB Securities rating of Turnstone Biologics (NASDAQ:TSBX) on 8/15/2023
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$76.94
-2.5%
8/15/2023Initiated bySVB Securities-Outperform$58.00LowView details for SVB Securities rating of Cytokinetics (NASDAQ:CYTK) on 8/15/2023
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
$2.32
+1.3%
8/15/2023Downgraded bySVB Securities-Outperform -> Market Perform$6.00LowView details for SVB Securities rating of Design Therapeutics (NASDAQ:DSGN) on 8/15/2023
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
$9.09
+2.2%
8/8/2023Initiated bySVB Securities-OutperformLowView details for SVB Securities rating of Relay Therapeutics (NASDAQ:RLAY) on 8/8/2023
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$82.45
+2.3%
8/8/2023Initiated bySVB Securities-Market Perform$42.00LowView details for SVB Securities rating of Nuvalent (NASDAQ:NUVL) on 8/8/2023
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$45.89
+2.4%
8/8/2023Initiated bySVB Securities-Outperform$33.00LowView details for SVB Securities rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/8/2023
Exelixis, Inc. stock logo
EXEL
Exelixis
$20.22
+0.2%
8/8/2023Initiated bySVB Securities-Market Perform$18.00LowView details for SVB Securities rating of Exelixis (NASDAQ:EXEL) on 8/8/2023
Quanterix Co. stock logo
QTRX
Quanterix
$24.28
-0.3%
8/8/2023Upgraded bySVB Securities-Market Perform -> Outperform$30.00LowView details for SVB Securities rating of Quanterix (NASDAQ:QTRX) on 8/8/2023
NovoCure Limited stock logo
NVCR
NovoCure
$15.31
+3.1%
8/4/2023Initiated bySVB Securities-Outperform$51.00LowView details for SVB Securities rating of NovoCure (NASDAQ:NVCR) on 8/4/2023
Belite Bio, Inc stock logo
BLTE
Belite Bio
$47.55
+3.7%
7/26/2023Initiated bySVB Securities-Outperform$25.00LowView details for SVB Securities rating of Belite Bio (NASDAQ:BLTE) on 7/26/2023
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$132.30
-1.6%
7/24/2023Upgraded bySVB Securities-Market Perform -> Outperform$115.00 -> $125.00LowView details for SVB Securities rating of Neurocrine Biosciences (NASDAQ:NBIX) on 7/24/2023
Cryoport, Inc. stock logo
CYRX
Cryoport
$15.89
+1.0%
7/13/2023Downgraded bySVB Securities-Outperform -> Market Perform$30.00 -> $10.00LowView details for SVB Securities rating of Cryoport (NASDAQ:CYRX) on 7/13/2023
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$49.81
+2.3%
7/10/2023Initiated bySVB Securities-Market Perform$66.00LowView details for SVB Securities rating of Bristol-Myers Squibb (NYSE:BMY) on 7/10/2023
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
$63.19
+3.2%
6/26/2023Target Raised bySVB Securities-$28.00 -> $56.00LowView details for SVB Securities rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 6/26/2023
Enhabit, Inc. stock logo
EHAB
Enhabit
$8.93
+0.3%
6/20/2023Initiated bySVB Securities-Underperform$10.00LowView details for SVB Securities rating of Enhabit (NYSE:EHAB) on 6/20/2023
PepGen Inc. stock logo
PEPG
PepGen
$14.66
-2.8%
6/14/2023Target Lowered bySVB Securities-$33.00 -> $28.00LowView details for SVB Securities rating of PepGen (NASDAQ:PEPG) on 6/14/2023
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$518.22
-0.4%
6/14/2023Target Lowered bySVB Securities-$625.00 -> $560.00LowView details for SVB Securities rating of UnitedHealth Group (NYSE:UNH) on 6/14/2023
Oculis Holding AG stock logo
OCS
Oculis
$12.70
+0.9%
6/12/2023Initiated bySVB Securities-OutperformLowView details for SVB Securities rating of Oculis (NASDAQ:OCS) on 6/12/2023
CureVac stock logo
CVAC
CureVac
$3.43
-1.4%
6/8/2023Initiated bySVB Securities-Outperform$13.00LowView details for SVB Securities rating of CureVac (NASDAQ:CVAC) on 6/8/2023
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
$23.92
+0.3%
6/5/2023Target Lowered bySVB Securities-$50.00 -> $35.00LowView details for SVB Securities rating of Castle Biosciences (NASDAQ:CSTL) on 6/5/2023
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$76.54
+3.2%
6/5/2023Downgraded bySVB Securities-Market Perform -> Underperform$48.00 -> $43.00LowView details for SVB Securities rating of Blueprint Medicines (NASDAQ:BPMC) on 6/5/2023
Elevation Oncology, Inc. stock logo
ELEV
Elevation Oncology
$3.00
+3.4%
5/30/2023Upgraded bySVB Securities-Market Perform -> Outperform$5.00 -> $8.00LowView details for SVB Securities rating of Elevation Oncology (NASDAQ:ELEV) on 5/30/2023
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
$162.38
+0.3%
5/26/2023Upgraded bySVB Securities-Market Perform -> Outperform$147.00 -> $170.00LowView details for SVB Securities rating of Universal Health Services (NYSE:UHS) on 5/26/2023
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$133.34
-0.5%
5/24/2023Target Lowered bySVB Securities-Outperform$170.00 -> $145.00LowView details for SVB Securities rating of Agilent Technologies (NYSE:A) on 5/24/2023
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$32.56
+5.5%
5/12/2023Downgraded bySVB Securities-Outperform -> Market Perform$40.00LowView details for SVB Securities rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/12/2023
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$9.29
+0.7%
5/5/2023Target Lowered bySVB Securities-$43.00 -> $42.00LowView details for SVB Securities rating of Vir Biotechnology (NASDAQ:VIR) on 5/5/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$953.42
+0.7%
5/5/2023Target Lowered bySVB Securities-$976.00 -> $895.00LowView details for SVB Securities rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/5/2023
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$20.89
+2.9%
5/5/2023Target Raised bySVB Securities-$39.00 -> $40.00LowView details for SVB Securities rating of Privia Health Group (NASDAQ:PRVA) on 5/5/2023
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$56.14
+1.0%
5/5/2023Target Raised bySVB Securities-$120.00 -> $127.00LowView details for SVB Securities rating of Lantheus (NASDAQ:LNTH) on 5/5/2023
Amedisys, Inc. stock logo
AMED
Amedisys
$93.68
-0.2%
5/5/2023Target Lowered bySVB Securities-$96.00 -> $81.00LowView details for SVB Securities rating of Amedisys (NASDAQ:AMED) on 5/5/2023
Alignment Healthcare, Inc. stock logo
ALHC
Alignment Healthcare
$6.73
+0.9%
5/5/2023Target Lowered bySVB Securities-$24.00 -> $12.00LowView details for SVB Securities rating of Alignment Healthcare (NASDAQ:ALHC) on 5/5/2023
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
$25.14
+4.0%
5/5/2023Target Lowered bySVB Securities-$37.00 -> $34.00LowView details for SVB Securities rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 5/5/2023
AbCellera Biologics Inc. stock logo
ABCL
AbCellera Biologics
$5.11
+1.8%
5/5/2023Target Lowered bySVB Securities-$16.00 -> $15.00LowView details for SVB Securities rating of AbCellera Biologics (NASDAQ:ABCL) on 5/5/2023
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$740.16
+0.6%
5/1/2023Target Raised bySVB Securities-$410.00 -> $458.00LowView details for SVB Securities rating of Eli Lilly and Company (NYSE:LLY) on 5/1/2023
Danaher Co. stock logo
DHR
Danaher
$242.95
-1.2%
5/1/2023Initiated bySVB Securities-Outperform$300.00LowView details for SVB Securities rating of Danaher (NYSE:DHR) on 5/1/2023
Humana Inc. stock logo
HUM
Humana
$370.28
+0.7%
4/27/2023Target Lowered bySVB Securities-$640.00 -> $600.00LowView details for SVB Securities rating of Humana (NYSE:HUM) on 4/27/2023
AlloVir, Inc. stock logo
ALVR
AlloVir
$0.72
+7.0%
4/26/2023Target Raised bySVB Securities-$16.00 -> $19.00LowView details for SVB Securities rating of AlloVir (NASDAQ:ALVR) on 4/26/2023
Prothena Co. plc stock logo
PRTA
Prothena
$28.38
+3.5%
4/24/2023Initiated bySVB Securities-Outperform$80.00LowView details for SVB Securities rating of Prothena (NASDAQ:PRTA) on 4/24/2023
Merus stock logo
MRUS
Merus
$41.00
+2.3%
4/17/2023Target Raised bySVB Securities-Outperform$35.00 -> $48.00LowView details for SVB Securities rating of Merus (NASDAQ:MRUS) on 4/17/2023
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$28.63
+6.4%
4/13/2023Target Lowered bySVB Securities-Market Perform$14.00 -> $13.00LowView details for SVB Securities rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 4/13/2023
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$34.47
+4.6%
4/13/2023Target Raised bySVB Securities-Outperform$25.00 -> $27.00LowView details for SVB Securities rating of BridgeBio Pharma (NASDAQ:BBIO) on 4/13/2023
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$32.56
+5.5%
4/12/2023Upgraded bySVB Securities-Market Perform -> Outperform$21.00 -> $35.00LowView details for SVB Securities rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 4/12/2023
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$23.01
+2.3%
4/11/2023Initiated bySVB Securities-Market Perform$25.00LowView details for SVB Securities rating of Corcept Therapeutics (NASDAQ:CORT) on 4/11/2023
Innate Pharma S.A. stock logo
IPHA
Innate Pharma
$2.50
+1.2%
4/10/2023Target Raised bySVB Securities-$9.00 -> $10.00LowView details for SVB Securities rating of Innate Pharma (NASDAQ:IPHA) on 4/10/2023
Arcellx, Inc. stock logo
ACLX
Arcellx
$64.89
+5.4%
3/30/2023Target Raised bySVB Securities-$35.00 -> $39.00LowView details for SVB Securities rating of Arcellx (NASDAQ:ACLX) on 3/30/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$953.42
+0.7%
3/27/2023Upgraded bySVB Securities-Market Perform -> Outperform$834.00 -> $976.00LowView details for SVB Securities rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 3/27/2023
Incyte Co. stock logo
INCY
Incyte
$57.66
+0.5%
3/24/2023Upgraded bySVB Securities-Underperform -> Market Perform$61.00LowView details for SVB Securities rating of Incyte (NASDAQ:INCY) on 3/24/2023
Rain Oncology Inc. stock logo
RAIN
Rain Oncology
$1.21
-1.6%
3/21/2023Initiated bySVB Securities-Outperform$11.00LowView details for SVB Securities rating of Rain Oncology (NASDAQ:RAIN) on 3/21/2023
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
$25.51
+1.0%
3/17/2023Initiated bySVB Securities-Market Perform$48.00LowView details for SVB Securities rating of PTC Therapeutics (NASDAQ:PTCT) on 3/17/2023
Centessa Pharmaceuticals plc stock logo
CNTA
Centessa Pharmaceuticals
$9.26
+24.1%
3/17/2023Initiated bySVB Securities-Outperform$6.00LowView details for SVB Securities rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 3/17/2023
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$35.49
+0.7%
3/16/2023Downgraded bySVB Securities-Outperform -> Market Perform$42.00LowView details for SVB Securities rating of Halozyme Therapeutics (NASDAQ:HALO) on 3/16/2023
Seagen Inc. stock logo
SGEN
Seagen
$228.74
-0.1%
3/14/2023Target Raised bySVB Securities-$141.00 -> $229.00LowView details for SVB Securities rating of Seagen (NASDAQ:SGEN) on 3/14/2023
Fulcrum Therapeutics, Inc. stock logo
FULC
Fulcrum Therapeutics
$8.85
+8.6%
3/10/2023Target Lowered bySVB Securities-$18.00 -> $10.00LowView details for SVB Securities rating of Fulcrum Therapeutics (NASDAQ:FULC) on 3/10/2023
Morphic Holding, Inc. stock logo
MORF
Morphic
$39.70
+2.6%
3/8/2023Target Raised bySVB Securities-$45.00 -> $56.00LowView details for SVB Securities rating of Morphic (NASDAQ:MORF) on 3/8/2023
argenx SE stock logo
ARGX
argenx
$401.48
+1.7%
3/3/2023Target Raised bySVB Securities-$430.00 -> $435.00LowView details for SVB Securities rating of argenx (NASDAQ:ARGX) on 3/3/2023
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$7.42
+4.4%
3/1/2023Target Lowered bySVB Securities-$30.00 -> $23.00LowView details for SVB Securities rating of AdaptHealth (NASDAQ:AHCO) on 3/1/2023
Veradigm Inc. stock logo
MDRX
Veradigm
$8.54
+0.5%
3/1/2023Target Lowered bySVB Securities-$24.00 -> $17.00LowView details for SVB Securities rating of Veradigm (NASDAQ:MDRX) on 3/1/2023
Structure Therapeutics Inc. stock logo
GPCR
Structure Therapeutics
$49.00
+4.3%
2/28/2023Initiated bySVB Securities-Outperform$33.00LowView details for SVB Securities rating of Structure Therapeutics (NASDAQ:GPCR) on 2/28/2023
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$68.29
+2.3%
2/28/2023Initiated bySVB Securities-Outperform$36.00LowView details for SVB Securities rating of Disc Medicine (NASDAQ:IRON) on 2/28/2023
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$0.71
+3.6%
2/24/2023Target Lowered bySVB Securities-$5.00 -> $3.00N/AView details for SVB Securities rating of Nektar Therapeutics (NASDAQ:NKTR) on 2/24/2023
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$76.54
+3.2%
2/24/2023Target Lowered bySVB Securities-$45.00 -> $38.00LowView details for SVB Securities rating of Blueprint Medicines (NASDAQ:BPMC) on 2/24/2023
Moderna, Inc. stock logo
MRNA
Moderna
$87.41
-6.7%
2/24/2023Downgraded bySVB Securities-Market Perform -> Underperform$111.00 -> $93.00LowView details for SVB Securities rating of Moderna (NASDAQ:MRNA) on 2/24/2023
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$51.40
+2.8%
2/23/2023Target Lowered bySVB Securities-$34.00 -> $27.00LowView details for SVB Securities rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/23/2023
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$20.60
+1.1%
2/23/2023Upgraded bySVB Securities-Market Perform -> Outperform$34.00LowView details for SVB Securities rating of Teladoc Health (NYSE:TDOC) on 2/23/2023
AbbVie Inc. stock logo
ABBV
AbbVie
$174.08
-0.4%
2/10/2023Upgraded bySVB Securities-Underperform -> Market Perform$135.00 -> $153.00LowView details for SVB Securities rating of AbbVie (NYSE:ABBV) on 2/10/2023
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$422.91
0.0%
2/8/2023Target Lowered bySVB Securities-$374.00 -> $365.00LowView details for SVB Securities rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/8/2023
The Cigna Group stock logo
CI
The Cigna Group
$334.93
+0.8%
2/8/2023Target Lowered bySVB Securities-$335.00 -> $309.00LowView details for SVB Securities rating of The Cigna Group (NYSE:CI) on 2/8/2023
Seagen Inc. stock logo
SGEN
Seagen
$228.74
-0.1%
2/6/2023Downgraded bySVB Securities-Outperform -> Market Perform$162.00 -> $141.00LowView details for SVB Securities rating of Seagen (NASDAQ:SGEN) on 2/6/2023
Meta Platforms, Inc. stock logo
META
Meta Platforms
$468.11
-0.4%
2/2/2023Target Raised bySVB Securities-Outperform$220.00 -> $255.00LowView details for SVB Securities rating of Meta Platforms (NASDAQ:META) on 2/2/2023
Amgen Inc. stock logo
AMGN
Amgen
$291.12
-1.3%
2/2/2023Target Lowered bySVB Securities-$282.00 -> $267.00LowView details for SVB Securities rating of Amgen (NASDAQ:AMGN) on 2/2/2023
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$18.05
+4.9%
1/30/2023Initiated bySVB Securities-Outperform$50.00LowView details for SVB Securities rating of Denali Therapeutics (NASDAQ:DNLI) on 1/30/2023
Biohaven Ltd. stock logo
BHVN
Biohaven
$48.55
+3.5%
1/24/2023Initiated bySVB Securities-Outperform$24.00LowView details for SVB Securities rating of Biohaven (NYSE:BHVN) on 1/24/2023

MarketBeat Community Rating for SVB Securities

Community Ranking:  2.4 out of 5 (
2.4 of 5 stars)
Outperform Votes:  5,070 (Vote Outperform)
Underperform Votes:  5,371 (Vote Underperform)
Total Votes:  10,441
MarketBeat's community ratings are surveys of what our community members think about SVB Securities and other research firms. Vote "Outperform" if you believe SVB Securities's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVB Securities's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

My Account -